Louis P. Lacasse

Advitech Inc. is a health sciences and technology company, which develops, manufactures and marketes proprietary natural ingredients and formulations for oral and topical applications. Its products are based on three technological platforms: a superior multi-functional emulsification delivery system derived from plant seed oleosomes for formulation application in the topical cosmetic, OTC, Rx and natural personal care specialty ingredient markets, XP-828L for immune mediated inflammatory disorders and IM for anti-aging and wound healing. Advitech was founded in 1997 and is headquartered in Québec, Canada

Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA.

Sofinov, Societe Financiere d'Innovation, Inc. provides investment services. The firm assists new and expanding firms in key innovative sectors, including information technology, life sciences, and industrial goods, such as aeronautics and environmental technology. The company is headquartered in Montreal, Canada.

Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies.

CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London.

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada.

GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal.

Emerillon Therapeutics, Inc. used to develop genomics-based drugs for human complex diseases through its unique RCS mouse platform technology, its access to human patient samples, and its expertise in high throughput mutation screening and ion channel genomics. It also offers contract services, such as mutation detection using dHPLC, mouse genotyping, and speed congenesis. The company was founded in January 2003 and is headquartered was Montréal, Canada.

AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada.

Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada.

Natunola AgriTech, Inc. develops, manufactures and markets proprietary natural ingredients. It offers ingredients to the personal care, food and nutraceutical markets. The company was founded on June 30, 2004 and is headquartered in Winchester, Canada.

Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada.

Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada.